Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Sandner

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
Biological Chemistry|April 1, 2018
From molecules to patients: exploring the therapeutic role of soluble guanylate cyclase stimulatorsPeter Sandner
Medizin, Gesellschaft, Und Geschichte : Jahrbuch Des Instituts Fur Geschichte Der Medizin Der Robert Bosch Stiftung|December 6, 2006
[The quest of a project for the future: the National Socialistic leading discipline psychiatry and its "crisis of legitimation"]Peter Sandner
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 18, 2013
Modification of the salivary secretion assay in F508del mice--the murine equivalent of the human sweat testKaroline Droebner, Peter Sandner
Drug Discovery Today|May 13, 2008
Product-related research: how research can contribute to successful life-cycle managementPeter Sandner, Karl Ziegelbauer
Respiratory Medicine|March 26, 2017
Anti-fibrotic effects of soluble guanylate cyclase stimulators and activators: A review of the preclinical evidencePeter Sandner, Johannes Peter Stasch
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 22, 2015
From bedside to bench--meeting report of the 7th International Conference on cGMP "cGMP: generators, effectors and therapeutic implications" in Trier, Germany, from June 19th to 21st 2015Andreas Friebe, Peter Sandner, Roland Seifert
Biochemical Pharmacology|November 21, 2017
BAY 60-2770 activates two isoforms of nitric oxide sensitive guanylyl cyclase: Evidence for stable insertion of activator drugsAnne Sömmer, Peter Sandner, Sönke Behrends
Handbook of Experimental Pharmacology|December 18, 2008
Erectile dysfunction and lower urinary tractPeter Sandner, Dieter Neuser, Erwin Bischoff
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 20, 2019
cGMP: a unique 2nd messenger molecule - recent developments in cGMP research and developmentAndreas Friebe, Peter Sandner, Achim Schmidtko
Basic Research in Cardiology|May 17, 2018
cGMP at the centre of attention: emerging strategies for activating the cardioprotective PKG pathwayMin Park, Peter Sandner, Thomas Krieg
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
Biological Chemistry|April 1, 2018
From molecules to patients: exploring the therapeutic role of soluble guanylate cyclase stimulatorsPeter Sandner
Medizin, Gesellschaft, Und Geschichte : Jahrbuch Des Instituts Fur Geschichte Der Medizin Der Robert Bosch Stiftung|December 6, 2006
[The quest of a project for the future: the National Socialistic leading discipline psychiatry and its "crisis of legitimation"]Peter Sandner
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 18, 2013
Modification of the salivary secretion assay in F508del mice--the murine equivalent of the human sweat testKaroline Droebner, Peter Sandner
Drug Discovery Today|May 13, 2008
Product-related research: how research can contribute to successful life-cycle managementPeter Sandner, Karl Ziegelbauer
Respiratory Medicine|March 26, 2017
Anti-fibrotic effects of soluble guanylate cyclase stimulators and activators: A review of the preclinical evidencePeter Sandner, Johannes Peter Stasch
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 22, 2015
From bedside to bench--meeting report of the 7th International Conference on cGMP "cGMP: generators, effectors and therapeutic implications" in Trier, Germany, from June 19th to 21st 2015Andreas Friebe, Peter Sandner, Roland Seifert
Biochemical Pharmacology|November 21, 2017
BAY 60-2770 activates two isoforms of nitric oxide sensitive guanylyl cyclase: Evidence for stable insertion of activator drugsAnne Sömmer, Peter Sandner, Sönke Behrends
Handbook of Experimental Pharmacology|December 18, 2008
Erectile dysfunction and lower urinary tractPeter Sandner, Dieter Neuser, Erwin Bischoff
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 20, 2019
cGMP: a unique 2nd messenger molecule - recent developments in cGMP research and developmentAndreas Friebe, Peter Sandner, Achim Schmidtko
Basic Research in Cardiology|May 17, 2018
cGMP at the centre of attention: emerging strategies for activating the cardioprotective PKG pathwayMin Park, Peter Sandner, Thomas Krieg
Pageof 11